Under mounting pressure in diabetes, Eli Lilly has just become the latest drugmaker to undergo a major shakeup. The pharma giant on Thursday announced plans to cut 3,500 employees by the end of the year as it shoots to achieve
read moreThe outlook brightened today for Bristol-Myers Squibb’s Opdivo as combo med as the drugmaker released more results from a test of its Opdivo-plus-Yervoy combination as a first-line treatment in kidney cancer. The overall survival results were promising enough that BMS
read moreCost of clinical negligence claims is rising at a faster rate year-on-year than NHS funding More: NHS negligence bill set to double Source: News
read moreWins for Cambridge University Hospitals, The PBC Foundation and Nottingham University Hospitals More: 3 UK wins in Practice to Policy Health Awards Source: News
read moreDecision follows halting of Keytruda trials in July due to potential risks to patients More: FDA puts Bristol-Myers Squibb Opdivo trials on hold Source: News
read morePharmacy Times More: FDA approves antibacterial drug for complicated urinary tract infections Source: MDlinx
read more© 1994 - 2026 B.M. Pharmaceuticals